Advanced wound care, made personal

A lightweight device, that fits seamlessly into standard of care A lightweight device, that fits seamlessly into standard of care
Swiss Medical Technology

A lightweight device, that fits seamlessly into standard of care

Get to know our product

The benefits of COMS®-Technology*

Treatment of chronic wounds represents a challenge for both the patient and modern healthcare systems

How it works
Accelerated Wound Closure

Accelerated Wound Closure

To produce a durable closure for hard-to-heal wounds.

Ease of Use

Ease of Use

Treatment is non-invasive and requires minimal staff supervision.

Decreased Costs

Decreased Costs

Healing of chronic wounds significantly decreases the financial burden of modern health care.

Platform Technology

Platform Technology

The underlying mechanism of action can be applied to different pathological conditions.


*The COMS® One therapy system is not cleared in the US.

Who are we?

Who are we?

We are a young company founded and based in Zurich, Switzerland since 2016. The Piomic family consists of biologists, engineers, entrepreneurs, designers, seniors and a broad group of supporters. Staffed with experts from different backgrounds and a common goal: By developing a therapy which is safe and effective, we want to set a better future for patients in need.

More about us

Do you want to contribute to our vision?

Do you want to contribute to our vision?

In order to maximize our global impact, we are looking for investors who share our vision and wish to shape the future of wound care with us.

Information for investors

Latest news

Karina Candrian joins the Board of Directors

21 Jun 2022

As a serial MedTech entrepreneur, Karina Candrian has more than 20 years of practical experience in the healthcare industry and covers various functions along the entire value chain.

Read more
Karina Candrian joins the Board of Directors
Publication of COMS01 clinical trial results in the Journal of Wound Care

21 Jun 2022

In a multicentre clinical trial COMS® therapy significantly reduced the time to wound closure for hard-to-heal wounds when compared with Standard of Care (SOC) alone

Read more
Publication of COMS01 clinical trial results in the Journal of Wound Care
Piomic selected as Ground-Breaking Swiss Startup Innovation

21 Jun 2022

Piomic selected as groundbreaking Swiss start-up innovation

Read more
Piomic selected as Ground-Breaking Swiss Startup Innovation
20th SAfW Symposium – Advantages of COMS® technology

24 Nov 2021

Dr. Jürg Traber and Maria Signer from Venenklinik Bellevue shared their experience about the advantages of COMS® Therapy at the 20th SAfW Symposium.

Read more
20th SAfW Symposium – Advantages of COMS® technology
Don't miss our updates!
You must complete your email.
You must accept our Privacy Policy

Our Partners

Do you want to cooperate with us?

We are constantly trying to expand our interdisciplinary know-how and increase the impact of our novel technology on the lives of patients. Therefore we are looking to conncet to the brightest minds in their field of expertise and share our knowledge to create easy-to-use products and innovative wound care solutions.